Ann: Pharmaceutical Clinical Study Commences, page-9

My post and throughts from April this year: Pfizer in my mind is most obvious.  

"Clinical study protocol was developed in consultation with a major US pharmaceutical and healthcare company."

"With the aid of its USA pharmaceutical partner, OBJ has succeeded in developing a new topical formulation and array combination that has shown, in laboratory studies, to be very effective at delivering IBU through the skin. "

That's a pre-partnership clinical study in my opinion only.  

That's also just days after the un-named manufacturer has been confirmed.    

What's the Drug named in the ASX announcement?

Ibuprofen.   

What are brand named drugs of Ibuprofen?

Source: Wiki.

Top three Brands named - Advil, Motrin, Nurofen.  

Who owns them?

Advil - Pfizer.  
Motrin - Johnson & Johnson.
Nurofen - Reckitt Benckiser.  

Lubricen used in BG was OBJ's TM formulation.  If we are partnering with Pfizer, Johnson & Johnson &/or RB for BG, not too hard to see that they may not wish to be using someone else proprietary formulation if they're already in that space and have their own brand names established.  

If you look between the lines of what's been announced the last week, this is the beginning of massive news in 2017.  

Localised patch for localised pain treatment, bypassing first pass metabolism.  

Distributed by largest pharmaceutical companies in the world.  

Kiwi.